Principles of Oncogenesis Flashcards

1
Q

What is neoplasia usually the interaction between?

A

Environmental and genetic factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List some biologic agents that are oncogenic pathogens

A

Retroviruses (FeLV) - express oncogenes
Poxviruses (BPV and equine sarcoids)
Others (Helicobacter pylori and gastric carcinoma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List examples of environmental carcinogens

A

Chemical
Radionucleic
Radiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a mitogen?

A

Causes cell proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define oncogene

A

contribute to formation of a cancer when inappropriately activated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does activating/gain of function mutation of proto-oncogenes cause?

A

promote proliferation, inhibit apoptosis or both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name 2 tumour suppressor genes

A

Rb and p53
Normally act to prevent cells proliferating out of control
For function to be lost, both copies of the gene need to be mutated/deleted/silenced

Rb - transduces growth-inhibitory signals that originate largely outside the cell and determines whetherh or not cell cycle progression should proceed.

p53 - receives input from intracellular operating systems, such that if cell viability is suboptimal, it calls a halt to cell cycle progression, until such time as these new conditions have been normalised. Can also trigger apoptosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What can increase susceptibility to malignant transformation?

A

insertion, deletion, chromosomal rearrangement or missense mutation of:
oncogenes or tumour suppressor genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the multi-step carcinogenesis model?

A

Initiation
Promotion
Progression

These depend on accumulation of several different mutations (usually at least 10-12). Thus, cumulative mutations in several oncogenes and tumour suppressor genes are required before a clinically significant tumour can develop.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the Hallmarks of Cancer (Hanahan and Weinberg)? 6

A
Sustaining proliferative signalling
Evading growth suppressors
Activating invasion and metastases
Enabling replicative immorality
Inducing angiogenesis
Resisting cell death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What tumours do the sex hormones predispose to?

A

Oestrogen/progesterone - mammary tumours

Androgens - prostatic carcinoma and perianal adenoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List some common breed predispositions

A

Boxers - lymphoma, MCT, others
Flat coated retrievers - STS
Irish Wolfhound - OSA
GSD - HSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How can sustaining proliferative signalling be achieved by tumour cells? 3

A

Secretion of endogenous growth factors
Mutation of growth factor receptors
Mutation of intracellular signalling molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Outline MCT and KIT mutations.

How does this affect novel treatment?

A

N.b. KIT is a RTK

Mast cells normally rely on stem cell factor (SCF) to survive and this acts through the KIT pathway. In these tumours, there is a mutation in the juxtamembrane portion of the RTK-R meaning that the KIT pathway is constitutively active.

NOVEL TREATMENT: RTK inhibitors include:
Toceranib and Masitibib
(Secondary effect of also inhibiting angiogenesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How can tumour cells resist cell death? 2

A

EXTRINSIC PATHWAY - receives and processes EC death-inducing signals

INTRINSIC PATHWAY - sensing and integrating variety of singals of intracellular membrane

Each culminates in the activation of the Caspase cascade –> apoptosis.

Many cancer cells downregulate death receptors or upregulate members of the Bcl-2 family to this end. This can also provide some resistance to cytotoxic anti-cancer drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Define combination chemotherapy

A

Modern treatment technique

Attack the cancer on several biological fronts simultaneously

17
Q

How do tumour cells enable replicative immortality?

A

Telomerase is upregulated in the vast majority of malignant cells –> immortality. THis is a specialised DNA polymerase that adds telomere repeat segments to the ends of DNA

18
Q

How do tumours induce angiogenesis?

A

Many tumours secrete angiogenic factors (VEGF)

19
Q

How do tumour cells invade tissues and metastasise? 2

A

Produce MMPs

Alter cell adhesion molecules to detach and migrate (e.g. loss of E-cadherin by carcinoma cells)

20
Q

Name 2 emerging hallmarks of cancer

A

Deregulating cellular energetic/reprogramming energy metabolism

Evading immune detection

21
Q

How do tumour cells alter their energy metabolism?

A

Re-programme their glucose metabolism (limiting metabolism largely to glycolysis rather than mitochondrial oxidative phosphorylation which is achieved in a number of ways such as upregulating GLUT1 transports for more efficient glucose uptake)

22
Q

How do tumour cells evade immune destruction?

A

WHAT?
Avoid immunosurveillance
Downregulate immune effector mechanisms
Induce immunological tolerance

HOW?
downregulating immunogenic Ags
Kill tumour-infiltrating WBCs
Produce immunosuppressive mediators
Induce tolerance
23
Q

What are the 2 new enabling characteristics of cancer?

A

Genome instability and mutation

Tumour-promoting inflammation

24
Q

How do tumour cells become genetically unstable? 3

A

increased sensitivity to mutagenic agents

breakdown in one or several components of the genome maintenance machinery

both

25
Does inflammation aid or hinder inflammation?
Infiltrating inflammatory cells enhance tumourigenesis. Thus inflammation may paradoxically enhance the malignant potential of the tumour by supplying bioactive molecules (GFs, angiogenic mediators and immunosuppressive cytokines)
26
List 2 examples of where anti-inflammatory drugs have been used against cancer.
COX-2 inhibitors -decrease risk of bladder cancer ASPIRIN - prevent bowel cancer